The market is forcing a reaction from either the Deutsche Bank's management or the German government, says Gray Wolf Capital Management's Bill Smith.
Biotech stocks are under pressure as California proposes a "Drug Price Relief Act" to curb the high cost of drugs after Mylan's EpiPen controversy. The "Fast Money" traders share their views on the biotech sector.
At the first presidential debate, Republican candidate Donald Trump responds to Democratic candidate Hillary Clinton regarding his attack on President Obama's U.S. citizenship and Trump's federal lawsuit.
All Trump has to do is act "presidential" to win Monday night's debate. Clinton’s task far more complex, say two GOP strategists.
Ole Hansen, head of commodity strategy at Saxo Bank, talks about the need for OPEC to make agreements on oil production at Algiers.
CNBC's Seema Mody reports on all the market moving events in Europe today, including Denmark's Maersk to split into two companies.
The White House said for the first time that it appears the weekend attacks were an act of terrorism.
A 10 basis points cut to interest rates might not be much, but BOJ's Kuroda needs to show the market that he will act, says Keio Business School's Seki Obata.
CNBC's Akiko Fujita outlines possible policy moves for the Bank of Japan, and speaks to former BOJ official Sayuri Shirai, who says that no action would ruin its credibility.
CNBC anchors Steve and Karen discuss the Bank of Japan, which is expected to act this week.